Professional Documents
Culture Documents
Financial Conflict of Interest IntElect Medical, Inc. Boston Scientific Neuromodulation, Corp. Neuros Medical, Inc. Cardionomic, Inc. Autonomic Technologies, Inc. Surgical Information Sciences, Inc.
Neuromodualtion Market
$2.7 Billion - 2011 Global Market $6.8 Billion - Estimated Global Market by 2017
Transparency Market Research, 2012 Markets and Markets, 2013
~100,000 patients have been implanted with DBS systems ~50,000 currently alive => ~100,000 active IPGs stimulated at 100 Hz * 24 hours
DBS Technology
DBS Surgery
Stereotactic Frame Image Guidance
DBS Programming
Basic Questions
What is the electric field generated in the brain? What neural elements are we stimulating? How can we customize the stimulation to the patient?
Experimental Measurement
GPi Pathway
Neuron Models
Subthalamic Pathways
Voltage Distribution
C2 -6 mA 60 s 120 Hz
Network Modulation
Neuromodulation Dose
Controlled Release of Neurotransmitters Dependent Upon: Electrode Location Stimulus Pulse Stimulus Frequency Numerous Pathways Simultaneously Activated
Rigidity Target
Bradykinesia Target
Clinical Outcomes
Commercial Product
Current-Steering
Stimulus Waveforms
Biophysical Efficiency
Biophysical Efficiency
Experimental Testing
Stimulator Design
Adjustable Converter
Dynamic
Compliance Voltage
Energy Consumption
Dynamic Compliance
Fixed Dynamic
DBS Paradigm
Electrodes
Large Contact Surface Area High Charge Capacity Low Impedance Large Stimulation Volume Limited Specificity
vs.
Small Contact Surface Area Low Charge Capacity High Impedance Small Stimulation Volume Focal Specificity
Current Density
Current Density
Electrode-Tissue Interface
Electrode Impedance
ElectrodeElectrolyte Interface
Tissue Component
Electrode Impedance
Electrode Impedance